155 related articles for article (PubMed ID: 14525559)
1. Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
Centorrino F; Albert MJ; Berry JM; Kelleher JP; Fellman V; Line G; Koukopoulos AE; Kidwell JE; Fogarty KV; Baldessarini RJ
Bipolar Disord; 2003 Oct; 5(5):370-4. PubMed ID: 14525559
[TBL] [Abstract][Full Text] [Related]
2. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
Hirschfeld RM; Kasper S
Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine for acute affective episodes in bipolar disorder.
Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
[TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine treatment of refractory bipolar disorder: a retrospective chart review.
Ghaemi SN; Ko JY; Katzow JJ
Bipolar Disord; 2002 Feb; 4(1):70-4. PubMed ID: 12047498
[TBL] [Abstract][Full Text] [Related]
6. An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
Conway CR; Chibnall JT; Nelson LA; McGuire JM; Abraham PF; Baram VY; Grossberg GT; Carroll BJ
J Clin Psychopharmacol; 2006 Feb; 26(1):95-7. PubMed ID: 16415718
[No Abstract] [Full Text] [Related]
7. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
[TBL] [Abstract][Full Text] [Related]
9. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
Wagner KD; Kowatch RA; Emslie GJ; Findling RL; Wilens TE; McCague K; D'Souza J; Wamil A; Lehman RB; Berv D; Linden D
Am J Psychiatry; 2006 Jul; 163(7):1179-86. PubMed ID: 16816222
[TBL] [Abstract][Full Text] [Related]
11. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design.
Hummel B; Walden J; Stampfer R; Dittmann S; Amann B; Sterr A; Schaefer M; Frye MA; Grunze H
Bipolar Disord; 2002 Dec; 4(6):412-7. PubMed ID: 12519102
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine treatment of bipolar disorder.
Ghaemi SN; Berv DA; Klugman J; Rosenquist KJ; Hsu DJ
J Clin Psychiatry; 2003 Aug; 64(8):943-5. PubMed ID: 12927010
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
Pratoomsri W; Yatham LN; Sohn CH; Solomons K; Lam RW
Bipolar Disord; 2005; 7 Suppl 5():37-42. PubMed ID: 16225559
[TBL] [Abstract][Full Text] [Related]
14. Oxcarbazepine in bipolar disorder: a critical review of the literature.
Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S
Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019
[TBL] [Abstract][Full Text] [Related]
15. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
[TBL] [Abstract][Full Text] [Related]
16. Flying almost blind.
Leibenluft E
Am J Psychiatry; 2006 Jul; 163(7):1129-31. PubMed ID: 16816212
[No Abstract] [Full Text] [Related]
17. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.
Misdrahi D; Tournier M; Droulout T; Grolleau A; Titier K; Molimard M; Verdoux H
Eur Psychiatry; 2008 Sep; 23(6):409-12. PubMed ID: 18755575
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsants in the treatment of bipolar mania.
Goodnick PJ
Expert Opin Pharmacother; 2006 Mar; 7(4):401-10. PubMed ID: 16503812
[TBL] [Abstract][Full Text] [Related]
19. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.
Emrich HM; Dose M; von Zerssen D
J Affect Disord; 1985; 8(3):243-50. PubMed ID: 3160736
[TBL] [Abstract][Full Text] [Related]
20. [Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders].
Mosolov SN; Kostiukova EG; Ladyzhenskiĭ MIa
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):36-41. PubMed ID: 20037568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
